Retrospective study assessing whether PSA levels, PSA doubling time, Gleason score and prior therapy can predict measured uptake of [68Ga]PSMA-HBED-CC lesion uptake in recurrent/metastatic prostate cancer
Latest Information Update: 20 Dec 2018
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
Most Recent Events
- 20 Dec 2018 New trial record